Yang L - Search Results

1

Randomized, Double-Blind, Placebo-Controlled Trial of Shuanghua Baihe Tablets to Prevent Oral Mucositis in Patients With Nasopharyngeal Cancer Undergoing Chemoradiation Therapy.

Zheng B, Zhu X, Liu M, Yang Z, Yang L, Lang J, Shi M, Wu G, He X, Chen X, Xi X, Zhao D, Zhu G. Zheng B, et al. Among authors: yang l, yang z. Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):418-426. doi: 10.1016/j.ijrobp.2017.10.013. Epub 2017 Oct 13. Int J Radiat Oncol Biol Phys. 2018. PMID: 29353657

2

Oral Mucosa Dose Parameters Predicting Grade ≥3 Acute Toxicity in Locally Advanced Nasopharyngeal Carcinoma Patients Treated With Concurrent Intensity-Modulated Radiation Therapy and Chemotherapy: An Independent Validation Study Comparing Oral Cavity versus Mucosal Surface Contouring Techniques.

Li K, Yang L, Hu QY, Chen XZ, Chen M, Chen Y. Li K, et al. Among authors: yang l. Transl Oncol. 2017 Oct;10(5):752-759. doi: 10.1016/j.tranon.2017.06.011. Epub 2017 Jul 21. Transl Oncol. 2017. PMID: 28738294 Free PMC article.

3

Impact of dose volume parameters and clinical factors on acute radiation oral mucositis for locally advanced nasopharyngeal carcinoma patients treated with concurrent intensity-modulated radiation therapy and chemoradiotherapy.

Li K, Yang L, Xin P, Chen Y, Hu QY, Chen XZ, Chen M. Li K, et al. Among authors: yang l. Oral Oncol. 2017 Sep;72:32-37. doi: 10.1016/j.oraloncology.2017.06.026. Epub 2017 Jul 11. Oral Oncol. 2017. PMID: 28797459

4

[Concurrent control study of different radiotherapy for primary nasopharyngeal carcinoma: intensity-modulated radiotherapy versus conventional radiotherapy].

Zhang Y, Lin ZA, Pan JJ, Zheng Z, Yang L, Lin SJ, Zheng F. Zhang Y, et al. Among authors: yang l. Ai Zheng. 2009 Nov;28(11):1143-8. doi: 10.5732/cjc.009.10427. Ai Zheng. 2009. PMID: 19895733 Free article. Chinese.

5

Factors associated with overall survival in 1706 patients with nasopharyngeal carcinoma: significance of intensive neoadjuvant chemotherapy and radiation break.

Xu L, Pan J, Wu J, Pan C, Zhang Y, Lin S, Yang L, Chen C, Zhang C, Zheng W, Lin S, Ni X, Kong FM. Xu L, et al. Among authors: yang l. Radiother Oncol. 2010 Jul;96(1):94-9. doi: 10.1016/j.radonc.2010.04.006. Radiother Oncol. 2010. PMID: 20435361

6

The correlation between the comprehensive nutrition index and quality of life of patients with nasopharyngeal carcinoma treated by intensity-modulated radiotherapy.

Ma L, Wu T, Pan J, Kong X, Guo Q, Yang L, Zhang Y, Lin S, Chen C, Huang C. Ma L, et al. Among authors: yang l. Nutr Cancer. 2014;66(1):152-8. doi: 10.1080/01635581.2014.853815. Epub 2013 Dec 13. Nutr Cancer. 2014. PMID: 24328938

7

Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial.

Zhu AX, Park JO, Ryoo BY, Yen CJ, Poon R, Pastorelli D, Blanc JF, Chung HC, Baron AD, Pfiffer TE, Okusaka T, Kubackova K, Trojan J, Sastre J, Chau I, Chang SC, Abada PB, Yang L, Schwartz JD, Kudo M; REACH Trial Investigators. Zhu AX, et al. Among authors: yang l. Lancet Oncol. 2015 Jul;16(7):859-70. doi: 10.1016/S1470-2045(15)00050-9. Epub 2015 Jun 18. Lancet Oncol. 2015. PMID: 26095784 Clinical Trial.

8

Biochemical remission by chemoradiotherapy in male mediastinal choriocarcinoma with diffuse lung metastasis: A case report.

Zhang J, Wang ZJ, Yang B, Wei YY, Yang L, Hu Y, Hu YP. Zhang J, et al. Among authors: yang b, yang l. Oncol Lett. 2016 Apr;11(4):2615-2618. doi: 10.3892/ol.2016.4248. Epub 2016 Feb 18. Oncol Lett. 2016. PMID: 27073527 Free PMC article.

9

Effect of molecular targeted therapy combined with radiotherapy on the expression and prognostic value of COX-2 and VEGF in bone metastasis of lung cancer.

Hu Y, Ren H, Yang L, Jin C, Wei Y. Hu Y, et al. Among authors: yang l. J BUON. 2020 Mar-Apr;25(2):811-820. J BUON. 2020. PMID: 32521872 Free article.

10

Immunotherapy or antiangiogenic therapy plus chemotherapy as first-line treatment of patients with PD-L1(-) advanced non-squamous non-small cell lung cancer in a Chinese cohort.

Xia R, Li Y, Yang L, Huang M. Xia R, et al. Among authors: yang l. Cancer Med. 2023 Jul;12(13):14282-14292. doi: 10.1002/cam4.6101. Epub 2023 May 22. Cancer Med. 2023. PMID: 37212483 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53,576 results

Search Page